Mimedx (MDXG) Cash from Investing Activities (2011 - 2026)
Mimedx recorded quarterly Cash from Investing Activities of -$5.6 million in Q1 2026, down 1584.18% quarter-over-quarter from -$335000.0 in Q4 2025, and down 1289.66% year-over-year from $474255.1 in Q1 2025.
Mimedx's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$5.6 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 1289.66% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at -$12.1 million (down 205.73% YoY), while the FY2025 annual figure was -$6.9 million, up 28.14% from the prior year.
- Cash from Investing Activities came in at -$5.6 million for Q1 2026 at Mimedx, down from -$335000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $113000.0 in Q3 2024 to a low of -$6.0 million in Q1 2024.
- A 5-year average of -$1.6 million and a median of -$649000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities surged 117.41% in 2024 and slumped 4753.1% in 2025, its largest moves.
- Mimedx's Cash from Investing Activities stood at -$1.7 million in 2022, then jumped by 71.85% to -$481000.0 in 2023, then sank by 475.26% to -$2.8 million in 2024, then jumped by 87.89% to -$335000.0 in 2025, then slumped by 1584.18% to -$5.6 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$5.6 million, -$335000.0, and -$5.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -5.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.64 Mn |
| Mar 31, 2026 | -5.64 Mn |
| Dec 31, 2025 | -335,000.00 |
| Dec 31, 2025 | -335,000.00 |
| Sep 30, 2025 | -5.26 Mn |
| Sep 30, 2025 | -5.26 Mn |
| Jun 30, 2025 | -887,000.00 |
| Jun 30, 2025 | -887,000.00 |
| Mar 31, 2025 | -406,000.00 |
| Mar 31, 2025 | -406,000.00 |
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 113,000.00 |
| Sep 30, 2024 | 113,000.00 |
| Jun 30, 2024 | -905,000.00 |
| Jun 30, 2024 | -905,000.00 |
| Mar 31, 2024 | -6.02 Mn |
| Mar 31, 2024 | -6.02 Mn |
| Dec 31, 2023 | -481,000.00 |
| Dec 31, 2023 | -481,000.00 |
| Sep 30, 2023 | -649,000.00 |
| Sep 30, 2023 | -649,000.00 |
| Jun 30, 2023 | -348,000.00 |
| Jun 30, 2023 | -348,000.00 |
| Mar 31, 2023 | -677,000.00 |
| Mar 31, 2023 | -677,000.00 |
| Dec 31, 2022 | -1.71 Mn |
| Dec 31, 2022 | -1.71 Mn |
| Sep 30, 2022 | -374,000.00 |
| Sep 30, 2022 | -374,000.00 |
| Jun 30, 2022 | -429,000.00 |
| Jun 30, 2022 | -429,000.00 |
| Mar 31, 2022 | -148,000.00 |
| Mar 31, 2022 | -148,000.00 |
| Dec 31, 2021 | -314,000.00 |
| Dec 31, 2021 | -314,000.00 |
| Sep 30, 2021 | -580,000.00 |
| Sep 30, 2021 | -580,000.00 |
| Jun 30, 2021 | -422,000.00 |
| Jun 30, 2021 | -422,000.00 |
| Mar 31, 2021 | -2.08 Mn |
| Mar 31, 2021 | -2.08 Mn |
| Dec 31, 2020 | -2.27 Mn |
| Dec 31, 2020 | -2.27 Mn |
| Sep 30, 2020 | -710,000.00 |
| Sep 30, 2020 | -710,000.00 |
| Jun 30, 2020 | -486,000.00 |
| Jun 30, 2020 | -486,000.00 |
| Mar 31, 2020 | -1.09 Mn |
| Mar 31, 2020 | -1.09 Mn |
| Dec 31, 2019 | -793,000.00 |
| Dec 31, 2019 | -793,000.00 |
| Sep 30, 2019 | 2.06 Mn |
| Sep 30, 2019 | 2.06 Mn |
| Jun 30, 2019 | -330,000.00 |
| Jun 30, 2019 | -330,000.00 |
| Mar 31, 2019 | -433,000.00 |
| Mar 31, 2019 | -433,000.00 |
| Dec 31, 2018 | -1.19 Mn |
| Dec 31, 2018 | -1.19 Mn |
| Sep 30, 2018 | -2.45 Mn |
| Sep 30, 2018 | -2.45 Mn |
| Jun 30, 2018 | -2.47 Mn |
| Jun 30, 2018 | -2.47 Mn |
| Mar 31, 2018 | -3.11 Mn |
| Mar 31, 2018 | -3.11 Mn |
| Dec 31, 2017 | -1.26 Mn |
| Dec 31, 2017 | -1.26 Mn |
| Sep 30, 2017 | -1.39 Mn |
| Sep 30, 2017 | -1.39 Mn |
| Jun 30, 2017 | -1.78 Mn |
| Jun 30, 2017 | -1.78 Mn |
| Mar 31, 2017 | -969,000.00 |
| Mar 31, 2017 | -969,000.00 |
| Dec 31, 2016 | -1.23 Mn |
| Dec 31, 2016 | -1.23 Mn |
| Sep 30, 2016 | -1.73 Mn |
| Sep 30, 2016 | -1.73 Mn |
| Jun 30, 2016 | 573,000.00 |
| Jun 30, 2016 | 573,000.00 |
| Mar 31, 2016 | -9.29 Mn |
| Mar 31, 2016 | -9.29 Mn |
| Dec 31, 2015 | 1.59 Mn |
| Dec 31, 2015 | 1.59 Mn |
| Sep 30, 2015 | -1.11 Mn |
| Sep 30, 2015 | -1.11 Mn |
| Jun 30, 2015 | -117,000.00 |
| Jun 30, 2015 | -117,000.00 |
| Mar 31, 2015 | -1.05 Mn |
| Mar 31, 2015 | -1.05 Mn |
| Dec 31, 2014 | -9.85 Mn |
| Dec 31, 2014 | -9.85 Mn |
| Sep 30, 2014 | -873,000.00 |
| Sep 30, 2014 | -873,000.00 |
| Jun 30, 2014 | -800,000.00 |
| Jun 30, 2014 | -800,000.00 |
| Mar 31, 2014 | -634,000.00 |
| Mar 31, 2014 | -634,000.00 |
| Dec 31, 2013 | -491,027.00 |
| Dec 31, 2013 | -491,027.00 |
| Sep 30, 2013 | -1.14 Mn |
| Sep 30, 2013 | -1.14 Mn |
| Jun 30, 2013 | -1.32 Mn |
| Jun 30, 2013 | -1.32 Mn |
| Mar 31, 2013 | -73,534.00 |
| Mar 31, 2013 | -73,534.00 |
| Dec 31, 2012 | -235,136.00 |
| Dec 31, 2012 | -235,136.00 |
| Sep 30, 2012 | -163,366.00 |
| Sep 30, 2012 | -163,366.00 |
| Jun 30, 2012 | -191,704.00 |
| Jun 30, 2012 | -191,704.00 |
| Mar 31, 2012 | -46,794.00 |
| Mar 31, 2012 | -46,794.00 |
| Dec 31, 2011 | 181,809.00 |
| Dec 31, 2011 | 181,809.00 |
| Sep 30, 2011 | -274,473.00 |
| Sep 30, 2011 | -274,473.00 |
| Jun 30, 2011 | -181,500.00 |
| Jun 30, 2011 | -181,500.00 |
| Mar 31, 2011 | -428,344.00 |
| Mar 31, 2011 | -428,344.00 |